Moreover, mutation data demonstrated that 76 (18.36%) of BLCA samples had ARGs mutations, of which ADAMTSL1 (4%), and GLI2 (4%) had the highest mutation frequency (Figure 1F). This evidence concerns the gene ADAMTSL1 and bladder transitional cell carcinoma.